The HCC tissue from patients showed an upregulated MYLK-AS1 expression (P = 0.0007), downregulated miR424-5p expression (P = 0.0058), and upregulated E2F7 expression (P = 0.0002) when compared with the healthy tissue counterpart (Fig. 2a-c). This evidence concerns the gene E2F7 and hepatocellular carcinoma.